Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis

Purpose: Ranolazine is a novel anti-angina treatment approved in the United States for chronic stable angina. Ranolazine pharmacokinetics have not been studied previously in patients who receive maintenance hemodialysis. This study describes the pharmacokinetics of ranolazine and three major metabol...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ren Fail
Prif Awduron: Scoville, Bridget A., Segal, Jonathan H., Salama, Noha N., Heung, Michael, Bleske, Barry E., Eyler, Rachel F., Mueller, Bruce A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2019
Pynciau:
Clinical Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6442103/
https://ncbi.nlm.nih.gov/pubmed/30909832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2019.1585371
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg